Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fierce Pharma
Vor Bio's surprise $4B revival deal splits investor reactions
In response to the deal, Vor's stock price more than doubled in premarket trading, while RemeGen’s stock price in Hong Kong dropped 18% Thursday.
Angus Liu
Jun 26, 2025 10:55am
Novartis pens ProFound pact for cardiovascular disease targets
Jun 26, 2025 6:30am
Invivyd says Pemgarda sequel could be alternative to COVID shots
Jun 26, 2025 10:12am
Altimmune stock sinks on mixed ph. 2 MASH results for GLP-1 drug
Jun 26, 2025 8:41am
Hummingbird uses VISTA buzz to secure $290M pact for tumor drug
Jun 26, 2025 4:53am
FDA amplifies Medtronic recall of Bravo acid reflux test capsule
Jun 26, 2025 10:33am
More News
Alto’s phase 2 depression trial misses primary efficacy endpoint
Jun 26, 2025 9:28am
Cosmo to connect Medtronic GI Genius with Apple Vision Pro
Jun 25, 2025 4:00pm
FDA moves to block Olympus endoscope imports
Jun 25, 2025 12:05pm
Minovia skates SPAC-wards into public market
Jun 25, 2025 10:33am